Canada markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
150.47-0.90 (-0.59%)
At close: 04:00PM EDT
151.04 +0.57 (+0.38%)
After hours: 07:05PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts21212222
Avg. Estimate-1.11-1.06-3.6-1.87
Low Estimate-1.57-1.69-5.56-4.38
High Estimate-0.36-0.31-1.072.31
Year Ago EPS-2.211.15-3.52-3.6
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts22212626
Avg. Estimate442.73M459.44M1.87B2.3B
Low Estimate415M441M1.73B1.48B
High Estimate485M495.5M2B2.97B
Year Ago Sales318.75M750.53M1.83B1.87B
Sales Growth (year/est)38.90%-38.80%2.30%22.70%
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.-1.37-1.34-1.32-1.18
EPS Actual-2.211.15-1.1-0.52
Difference-0.842.490.220.66
Surprise %-61.30%185.80%16.70%55.90%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate-1.11-1.06-3.6-1.87
7 Days Ago-1.06-1.05-3.95-1.75
30 Days Ago-1.04-1.1-4.1-1.76
60 Days Ago-1.03-1.1-4.18-1.77
90 Days Ago-1.21-1.32-4.2-1.04
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days65124
Up Last 30 Days10112310
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days8939
Growth EstimatesALNYIndustrySector(s)S&P 500
Current Qtr.49.80%N/AN/AN/A
Next Qtr.-192.20%N/AN/AN/A
Current Year-2.30%N/AN/AN/A
Next Year48.10%N/AN/AN/A
Next 5 Years (per annum)-177.50%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A